In OSCC patients, mGPS is a potential independent prognostic factor of cancer-specific survival and OS (Farhan-Alanie, McMahon & McMillan, 2015), and preoperative circulating CRP levels are associated with pathological aggression and survival outcomes (Chen et al., 2011). This evidence concerns the gene CRP and cancer.